Alpha5- GABA A Receptor Modulators for the Treatment of Cognitive Impairment Associated with Huntington's Disease (Seeding Drug Discovery Award) (Joint with University of Sussex and University of Cardiff)

Project Details

StatusFinished
Effective start/end date1/09/1631/12/19

Funding

  • Wellcome Trust (516071): £45,592.00
  • Wellcome Trust (via SUSSEX): £370,601.00